Clin Osteol 2025; 30(3): 130-133

Recommended dual-energy X-ray absorptiometry (DXA) bone densitometry report formatMain theme

Jan Rosa, Vladimír Palička, Vít Zikán, Petr Kasalický, František Šenk, Richard Pikner, Milan Bayer, Ladislav Bortlík, Ludmila Brunerová, Pavel Horák, Štěpán Kutílek, Václav Vyskočil
Pracovní skupina SMOS

Introduction: In the last 2 years the number of DXA bone densitometry devices in the Czech Republic has increased substantially. The number of patients examined and the number of reports of individual DXA studies have increased proportionally. The accuracy and precision of the description is essential for the quality of care of patients with osteoporosis and other osteopathies. No recommended form of DXA examination report has been published in the Czech literature so far.

Methods: The key items of the Recommended Format were designed and developed by the SMOS Working Group using literature search and gathering experience from established DXA centres. The final form emerged from a detailed editing process within the Working Group.

Results: The Header includes the data relevant for all examinations performed on a given DXA device. The Results section may include an explanation of why the examination was performed differently from the standard examination and a comment on the evaluability of the examination. The original copy of the examination is a standard attachment to the description and failure to provide it is fundamental misconduct. The interpretation of the findings according to the T-score (postmenopausal women, men ≥ 50 years) for each Region of Interest (ROI) separately (Lumbar spine, Total Hip of one or both sides, Femoral Neck of one or both sides) is crurcial: BMD corresponds to the range (alternatively: BMD meets DXA criteria) of osteoporosis, osteopenia, or is within the range of normal values. The lowest BMD value found in any relevant ROI is decisive for the final classification. In premenopausal women and men < 50 years, the criteria for categorizing the findings are both the Z-score (within the normal range for age and sex at ≥ -1 SD, decrease at < -1 SD, significant decrease at ≤ -2 SD) as well ase the expression in the T-score system (i. e., normal/osteopenia/osteoporosis). In the case of BMD value(s) in the osteoporosis range, inclusion of the following (or similar) wording is essential: "Before a definitive diagnosis of primary osteoporosis can be established, it is necessary to exclude other osteopathies and possible causes of (secondary) osteoporosis". On repeated exams, it is necessary to compare with the previous examination, to describe the change in each ROI, to evaluate its significance/insignificance (taking into account both the above mentioned Least Significant Changer (LSC) value and the interval between examinations).

Conclusion: Implementation of the Recommended DXA Bone Densitometry Report Format should ensure a standard quality of DXA examination reports, which would ultimately help improve the care of patients with metabolic and other osteopathies.

Keywords: DXA bone densitometry, bone mineral density, BMD, reporting.

Published: September 1, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Rosa J, Palička V, Zikán V, Kasalický P, Šenk F, Pikner R, et al.. Recommended dual-energy X-ray absorptiometry (DXA) bone densitometry report format. Clinical Osteology. 2025;30(3):130-133.
Download citation

References

  1. Krueger D, Tanner SB, Szalat A, et al. DXA Reporting Updates: 2023 Official Positions of the International Society for Clinical Densitometry. J Clin Densitom. 2024;27:101437. doi: 10.1016/j.jocd.2023.101437. Go to original source...
  2. Slart RHJA, Punda M, Ali DS, et al. Updated practice guideline for dual-energy X-ray absorptiometry (DXA). Eur J Nucl Med Mol Imaging. 2025;52(2):539-563.
  3. Genant HK, Jergas M. Assessment of prevalent and incident vertebral fractures in osteoporosis research. Osteoporos Int. 2003;14 (Suppl 3):S43-S55 DOI 10.1007/s00198-002-1348-1. Go to original source...




Clinical Osteology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.